Handelsbanken Fonder AB - OBALON THERAPEUTICS INC ownership

OBALON THERAPEUTICS INC's ticker is OBLN and the CUSIP is 67424L100. A total of 58 filers reported holding OBALON THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Handelsbanken Fonder AB ownership history of OBALON THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$397,000
-30.6%
60,0000.0%0.01%
-28.6%
Q3 2017$572,000
-3.9%
60,0000.0%0.01%
-53.3%
Q2 2017$595,000
-7.2%
60,0000.0%0.02%
-16.7%
Q1 2017$641,000
+262.1%
60,000
+200.0%
0.02%
+260.0%
Q4 2016$177,00020,0000.01%
Other shareholders
OBALON THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
INTERWEST VENTURE MANAGEMENT CO 2,453,338$23,380,0006.09%
Tamarack Advisers, LP 547,536$5,218,0003.20%
LEVEL FOUR ADVISORY SERVICES, LLC 330,427$3,149,0000.28%
Moisand Fitzgerald Tamayo, LLC 6,875$281,0000.17%
FORMULA GROWTH LTD 108,998$1,039,0000.16%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 351,284$3,348,0000.15%
KORNITZER CAPITAL MANAGEMENT INC /KS 423,390$4,035,0000.07%
TIVERTON ASSET MANAGEMENT LLC 123,800$1,179,0000.07%
Granite Investment Partners, LLC 108,758$1,036,0000.06%
Bellevue Group AG 48,000$457,0000.05%
View complete list of OBALON THERAPEUTICS INC shareholders